These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 965969)

  • 21. The irreversible inhibition of brain L-glutamate-1-decarboxylase by (2RS,3E)-2-methyl-3,4-didehydroglutamic acid.
    Chrystal E; Bey P; Rando RR
    J Neurochem; 1979 May; 32(5):1501-7. PubMed ID: 438819
    [No Abstract]   [Full Text] [Related]  

  • 22. Free amino acids and glutamate decarboxylase activity in brain of mice during drug-induced convulsions.
    Tapia R; Pasantes H; Pérez de la Mora M; Ortega BG; Massieu GH
    Biochem Pharmacol; 1967 Mar; 16(3):483-96. PubMed ID: 6040378
    [No Abstract]   [Full Text] [Related]  

  • 23. Isolation of 4.5-dihydroxyisophthalic acid an inhibitor of brain glutamate decarboxylase, produced by a Streptomyces species.
    Endo A; Kitahara N; Oka H; Miguchi-Fukazawa Y; Terahara A
    Eur J Biochem; 1978 Jan; 82(1):257-9. PubMed ID: 620673
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of human and mouse brain glutamate decarboxylase by the alpha-keto analogs of cysteine and homocysteine.
    Reingold DF; Orlowski M
    Biochem Pharmacol; 1978; 27(21):2567-70. PubMed ID: 569487
    [No Abstract]   [Full Text] [Related]  

  • 25. In vivo and in vitro glycogenic effects of methionine sulfoximine are different in two inbred strains of mice.
    Bernard-Hélary K; Ardourel MY; Hévor T; Cloix JF
    Brain Res; 2002 Mar; 929(2):147-55. PubMed ID: 11864619
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Possible involvement of indolamines in the glycogenic effect of the convulsant methionine sulfoximine in rat brain.
    Hevor TK; Delorme P
    Experientia; 1990 Jul; 46(7):710-3. PubMed ID: 1695579
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased in vivo methylation of [3H]histamine in the methionine sulfoximine epileptogenic mouse brain.
    Schatz RA; Frye K; Sellinger OZ
    J Pharmacol Exp Ther; 1978 Dec; 207(3):794-800. PubMed ID: 731432
    [No Abstract]   [Full Text] [Related]  

  • 28. The inhibition of mouse brain glutamate decarboxylase by some structural analogues of L-glutamic acid.
    Taberner PV; Pearce MJ; Watkins JC
    Biochem Pharmacol; 1977 Feb; 26(4):345-9. PubMed ID: 849326
    [No Abstract]   [Full Text] [Related]  

  • 29. Effect of nucleotides and other inhibitors on the inactivation of glutamate decarboxylase.
    Martin DL; Martin SB
    J Neurochem; 1982 Oct; 39(4):1001-8. PubMed ID: 7119776
    [No Abstract]   [Full Text] [Related]  

  • 30. The role of 2-keto-4-pentenoic acid in seizures induced by allylglycine.
    Horton RW
    Biochem Pharmacol; 1978 May; 27(10):1471-7. PubMed ID: 29640
    [No Abstract]   [Full Text] [Related]  

  • 31. Kinetics of brain glutamate decarboxylase. Inhibition studies with N-(5'-phosphopyridoxyl) amino acids.
    Bayón A; Possani LD; Tapia R
    J Neurochem; 1977 Sep; 29(3):513-7. PubMed ID: 894306
    [No Abstract]   [Full Text] [Related]  

  • 32. Seizure susceptibility in the developing mouse and its relationship to glutamate decarboxylase and pyridoxal phosphate in brain.
    Tapia R; Pasantes-Morales H; Taborda E; Pérez de la Mora M
    J Neurobiol; 1975 Mar; 6(2):159-70. PubMed ID: 171340
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Folic acid and the inhibition of brain L-glutamic decarboxylase.
    Tunnicliff G; Ngo TT
    Experientia; 1977 Jan; 33(1):67-8. PubMed ID: 836423
    [No Abstract]   [Full Text] [Related]  

  • 34. Seizures induced by allylglycine, 3-mercaptopropionic acid and 4-deoxypyridoxine in mice and photosensitive baboons, and different modes of inhibition of cerebral glutamic acid decarboxylase.
    Horton RW; Meldrum BS
    Br J Pharmacol; 1973 Sep; 49(1):52-63. PubMed ID: 4207045
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Glycogen content and fructose-1, 6-biphosphatase activity in methionine sulfoximine epileptogenic mouse brain and liver after protein synthesis inhibition.
    Hevor TK; Delorme P; Gayet J
    Neuropathol Appl Neurobiol; 1985; 11(2):129-39. PubMed ID: 2991793
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mechanism of inactivation of brain glutamic decarboxylase by 3-bromopyruvate.
    Tunnicliff G; Ngo TT
    Int J Biochem; 1978; 9(4):249-52. PubMed ID: 648707
    [No Abstract]   [Full Text] [Related]  

  • 37. cis- and trans-Aconitic acids as inhibitors of glutamate decarboxylase.
    Endo A; Kitahara N
    Hoppe Seylers Z Physiol Chem; 1977 Oct; 358(10):1365-8. PubMed ID: 924365
    [No Abstract]   [Full Text] [Related]  

  • 38. The selective inhibition of hippocampal glutamic acid decarboxylase in zinc-induced epileptic seizures.
    Itoh M; Ebadi M
    Neurochem Res; 1982 Oct; 7(10):1287-98. PubMed ID: 7155279
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of variations in glutamic acid decarboxylase activity on acute oxygen poisoning.
    Segerbo B
    J Neurochem; 1981 Nov; 37(5):1125-9. PubMed ID: 7299391
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effects of some newer anaesthetics on the in vitro activity of glutamate decarboxylase and GABA transaminase in crude brain extracts and on the levels of amino acids in vivo.
    Dye DJ; Taberner PV
    J Neurochem; 1975 May; 24(5):997-1001. PubMed ID: 1141906
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.